Navigation Links
Psoriasis medication rises hope in the fight against multiple sclerosis
Date:3/7/2011

Fumaric acid salts have been in use against severe psoriasis for a long time. About ten years ago, researchers in Bochum speculated that they may also have a favourable effect on Multiple Sclerosis (MS) as a result of their TH2 polarizing mechanisms. In parallel to phase III studies, research is actively searching for the precise effective mechanisms. This has now been achieved by a neuroimmunological group at Bochum: fumaric acid salts detoxify radicals released during the inflammation process. In this way, they protect nerve and glial cells. Neurologists at the Ruhr University Hospital, St. Josef Hospital, working with Prof. Dr. Ralf Gold report early online in the leading neurology journal BRAIN.

Previous history. inspiration from dermatology

Like Multiple Sclerosis, psoriasis is an auto-immune disease, in which the immune system attack the body's own cells. In MS, the "insulating myelin layer" of the axons is destroyed in this way. About ten years ago, the RUB dermatologist Prof. Peter Altmeyer informed his colleague, the neurologist Prof. Horst Przuntek, that the mixture of fumaric acid salts registered for treatment of psoriasis under the trade name FUMADERM could possibly exert favourable effects in MS as well. In turn, the Swiss manufacturer Fumapharm sponsored a small study in Bochum. Ten patients were examined for a period of 48 weeks (Schimrigk et al European Journal of Neurology 2006, 13: 604�). In Parallel to this, Fumapharm supported basic research which Prof. Gold then performed at his MS Institute in Gttingen (Schilling et al. Clin Exp Immunology 2006; 145: 101-107).

Fumaric acid salts detoxify radicals and protect nerve cells

After that, the scenario moved rapidly: the US pharmaceutical company BiogenIdec with its focus in MS research took over Fumapharm AG and initiated a successful Phase II study (Kappos, Gold, Lancet 2008; 372: 1463󈞴). Parallel to this, the group around Prof. Gold, who had moved to Bochum in the meantime, intensively studied the effective mechanisms. It was seen that the effect of the fumaric acid salts, unlike that of "standard medications" against MS, is not merely based on the suppression or the modulation of the immune system, but detoxifies damaging "oxidative radicals" released during the inflammation processes and thus supports the survival of nerve cells. The Nrf2 transcription factor plays a central role in this context. "In this way, fumaric acid assumes a special position in the MS world as a "neuro-protective/antioxidant substance", Prof. Gold explains.

Results of new study are being expected in summer 2011

An international, placebo-controlled, blind study (DEFINE, Sponsor: BiogenIdec) with 1,200 MS patients and the fumaric acid salt BG12 has just been completed under the leadership of Prof. Gold. Evaluation is being expected for summer 2011. "If the study is successful, one could easily imagine that the antioxidant effect of the fumaric acid also synergizes with established MS medication such as interferon- thus forming an ideal combination therapy", Prof. Gold speculates. "This is significant insofar as both fumarates as well as interferon do not contain any long-term risks according to the current state of knowledge unlike many modern strong MS therapies."


'/>"/>

Contact: Dr. Ralf Gold
49-023-450-92410
Ruhr-University Bochum
Source:Eurekalert

Related medicine news :

1. Project Runways Tim Gunn Returns to Address Psoriasis(TM) and Empower Patients to be Confident in Their Personal Style
2. Psoriasis is More Than Skin Deep
3. Psoriasis Tied to Raised Heart Risk
4. LeAnn Rimes Brings Battle With Psoriasis to Center Stage
5. Acne, Psoriasis Meds Dont Raise Fracture Risk
6. Insurance Woes Can Add to Burden of Psoriasis
7. Beer Linked to Psoriasis in Women
8. Kids With Psoriasis Often at Risk of Being Bullied: Survey
9. Psoriasis Linked to Raised Heart Risks
10. Certain pain medications do not appear to be associated with skin cancer risk
11. Study supports alternative anti-seizure medication following acute brain injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2017)... ... 21, 2017 , ... For the past 10 years, the ... policymakers, and activists wanting to address equity issues in breastfeeding, and move the ... from a recent series of from this conference. , The opening two ...
(Date:5/19/2017)... ... , ... In a continuous effort to raise awareness of autism and common ... specializes in natural and organic latex mattresses, has announced that they will donate $1 ... their recent viral Facebook video receives, up to $10,000.00. , The ...
(Date:5/19/2017)... ... ... The Hill Agencies, a family managed firm that offers insurance management assistance ... announcing a joint charity initiative with the Boys and Girls Club of Kern County ... The Boys and Girls Club of Kern County gives young people in the Bakersfield ...
(Date:5/19/2017)... Chicago, IL (PRWEB) , ... May 18, 2017 , ... ... handles practices of all specialties and sizes and specializes in large group practices, is ... very competitive industry, but it has also set the standard in all aspects of ...
(Date:5/18/2017)... (PRWEB) , ... May 18, 2017 , ... Originally launched ... called the HighQ Learning Tab. Due to the rapid expansion of their product line, ... each type of product. Now, the HighQ brand will be any tablet product ...
Breaking Medicine News(10 mins):
(Date:5/10/2017)... , May 10, 2017 Radiology has ... unfortunately its costs have also spiraled to the number ... sent to radiology than ever before as the most ... For a patient with lower back pain an MRI ... anatomical reason for pain, resulting in entirely different treatment ...
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals Inc. ... a clinical-stage pharmaceutical company focused on the development ... the Canadian Intellectual Property Office has granted Oramed ... Administration of Exenatide". The patent covers Oramed,s invention ... GLP-1 is an incretin hormone that stimulates ...
(Date:5/6/2017)... , May 5, 2017   Provista , a proven ... than 200,000 customers, today announced Jim Cunniff as ... of executive and business experience to Provista, including most recently ... in California . He assumed his new ... is a great fit for Provista," says Jody Hatcher ...
Breaking Medicine Technology: